Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
The Journal of Applied Laboratory Medicine
|
August 22, 2022
Characterization of Casirivimab Plus Imdevimab, Sotrovimab, and Bamlanivimab Plus Etesevimab-Derived Interference in Serum Protein Electrophoresis and Immunofixation Electrophoresis
Ashley Rose Scholl, Dimitrios Korentzelos, Taylor E Forns, et al.
Cancer Investigation
|
May 10, 2014
Tumor acquisition for biomarker research in lung cancer
Marvaretta Stevenson, Jared Christensen, Debra Shoemaker, et al.
The Journal of Molecular Diagnostics : JMD
|
December 21, 2016
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists
Marilyn M Li, Michael Datto, Eric J Duncavage, et al.
The Journal of Molecular Diagnostics : JMD
|
December 19, 2017
Authors' Reply
Marilyn M Li, Michael Datto, Eric J Duncavage, et al.
American Journal of Clinical Pathology
|
March 18, 2011
Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature
Endi Wang, Charles Blake Hutchinson, Qin Huang, et al.
Molecular Cancer Therapeutics
|
February 22, 2012
Characterization of an oxaliplatin sensitivity predictor in a preclinical murine model of colorectal cancer
Mickey K Kim, Takuya Osada, William T Barry, et al.
Targeted Oncology
|
January 5, 2021
Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian Cancers
Catherine H Watson, Gloria Broadwater, Janice Wong, et al.
Leukemia & Lymphoma
|
August 11, 2011
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia
Mark C Lanasa, Patricia H Davis, Michael Datto, et al.
Plos One
|
September 12, 2025
Analytical validation (accuracy, reproducibility, limit of detection) and gene expression analysis of FoundationOneRNA assay for fusion detection in 189 clinical tumor specimens
Daokun Sun, Richard S P Huang, Michelle Green, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
The Journal of Applied Laboratory Medicine
|
August 22, 2022
Characterization of Casirivimab Plus Imdevimab, Sotrovimab, and Bamlanivimab Plus Etesevimab-Derived Interference in Serum Protein Electrophoresis and Immunofixation Electrophoresis
Ashley Rose Scholl, Dimitrios Korentzelos, Taylor E Forns, et al.
Cancer Investigation
|
May 10, 2014
Tumor acquisition for biomarker research in lung cancer
Marvaretta Stevenson, Jared Christensen, Debra Shoemaker, et al.
The Journal of Molecular Diagnostics : JMD
|
December 21, 2016
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists
Marilyn M Li, Michael Datto, Eric J Duncavage, et al.
The Journal of Molecular Diagnostics : JMD
|
December 19, 2017
Authors' Reply
Marilyn M Li, Michael Datto, Eric J Duncavage, et al.
American Journal of Clinical Pathology
|
March 18, 2011
Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature
Endi Wang, Charles Blake Hutchinson, Qin Huang, et al.
Molecular Cancer Therapeutics
|
February 22, 2012
Characterization of an oxaliplatin sensitivity predictor in a preclinical murine model of colorectal cancer
Mickey K Kim, Takuya Osada, William T Barry, et al.
Targeted Oncology
|
January 5, 2021
Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian Cancers
Catherine H Watson, Gloria Broadwater, Janice Wong, et al.
Leukemia & Lymphoma
|
August 11, 2011
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia
Mark C Lanasa, Patricia H Davis, Michael Datto, et al.
Plos One
|
September 12, 2025
Analytical validation (accuracy, reproducibility, limit of detection) and gene expression analysis of FoundationOneRNA assay for fusion detection in 189 clinical tumor specimens
Daokun Sun, Richard S P Huang, Michelle Green, et al.
Page
of 2